News

Fierce Biotech11h
TegMine, with ex-Stemcentrx scientists at the helm, bags tech from OBI to help fuel ADC ambitions
TegMine has identified Taiwan’s OBI as a company that can help advance its ambitions. The new deal secures TegMine the right ...
OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies
OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADCs) ...
OBI Pharma Inc.: OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI and TegMiner Enabling Technologies
OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates ...